The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases
about
Dynamic Consent: a potential solution to some of the challenges of modern biomedical research.Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia.Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.National information system for rare diseases with an approach to data architecture: A systematic review
P2860
The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The RUDY study platform - a no ...... rare musculoskeletal diseases
@en
The RUDY study platform - a no ...... rare musculoskeletal diseases.
@nl
type
label
The RUDY study platform - a no ...... rare musculoskeletal diseases
@en
The RUDY study platform - a no ...... rare musculoskeletal diseases.
@nl
prefLabel
The RUDY study platform - a no ...... rare musculoskeletal diseases
@en
The RUDY study platform - a no ...... rare musculoskeletal diseases.
@nl
P2093
P2860
P50
P1476
The RUDY study platform - a no ...... rare musculoskeletal diseases
@en
P2093
L Forestier-Zhang
P Wordsworth
P2860
P2888
P356
10.1186/S13023-016-0528-6
P50
P577
2016-11-08T00:00:00Z
P6179
1011153643